Breakdown | TTM | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|---|
Income Statement | ||||||
Total Revenue | 57.67B | 54.61B | 56.14B | 78.58B | 46.06B | 18.77B |
Gross Profit | 16.05B | 16.03B | 18.20B | 29.63B | 14.73B | -646.00M |
EBITDA | 25.58B | 24.43B | 25.78B | 37.13B | 21.09B | 4.52B |
Net Income | 9.16B | 9.22B | 10.92B | 18.62B | 8.08B | -2.70B |
Balance Sheet | ||||||
Total Assets | 122.60B | 122.78B | 95.92B | 93.83B | 90.66B | 62.62B |
Cash, Cash Equivalents and Short-Term Investments | 5.34B | 6.11B | 6.61B | 9.24B | 6.59B | 7.86B |
Total Debt | 23.53B | 25.35B | 19.63B | 17.19B | 19.93B | 15.37B |
Total Liabilities | 57.03B | 57.98B | 46.65B | 45.83B | 45.26B | 32.77B |
Stockholders Equity | 65.57B | 64.80B | 49.28B | 48.00B | 45.41B | 29.85B |
Cash Flow | ||||||
Free Cash Flow | 6.92B | 8.01B | 8.72B | 18.16B | 11.67B | 87.00M |
Operating Cash Flow | 19.82B | 20.12B | 19.96B | 28.31B | 17.00B | 4.80B |
Investing Cash Flow | -9.66B | -11.15B | -12.00B | -8.74B | -8.54B | -4.12B |
Financing Cash Flow | -9.59B | -8.84B | -8.66B | -18.05B | -6.33B | -2.71B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
78 Outperform | $123.00B | 13.21 | 15.88% | 3.17% | 2.45% | -17.08% | |
77 Outperform | $42.92B | 10.54 | 9.87% | 2.63% | 51.78% | -27.29% | |
76 Outperform | $327.91B | 20.67 | 9.38% | 4.22% | -5.02% | -23.13% | |
76 Outperform | $64.05B | 11.41 | 19.60% | 3.27% | -5.42% | -20.52% | |
74 Outperform | $23.48B | 8.29 | 18.88% | 2.54% | 10.98% | -19.25% | |
71 Outperform | $46.73B | 27.89 | 8.91% | 1.98% | -1.66% | -58.96% | |
65 Neutral | $15.17B | 7.61 | 4.09% | 5.20% | 3.87% | -62.32% |